Simon N. Pimstone has sold XENE and made no open-market buys since Sep 2019
Director at Xenon Pharmaceuticals Inc.
SEC CIK 0001620084 · Filings on SEC.gov ↗
Every filing
8 filings since Sep 2019, newest first
Xenon Pharmaceuticals Inc.
Director
Xenon Pharmaceuticals Inc.
Director
Xenon Pharmaceuticals Inc.
Director
Xenon Pharmaceuticals Inc.
Director
Xenon Pharmaceuticals Inc.
Director
Xenon Pharmaceuticals Inc.
Director
Xenon Pharmaceuticals Inc.
CEO
Xenon Pharmaceuticals Inc.
CEO
About Simon N. Pimstone
Insider Type: Person
Dr. Simon N. Pimstone is a physician, scientist, and biotech entrepreneur who co‑founded Xenon Pharmaceuticals Inc. (XENE), where he has served as Director, President, and Chief Executive Officer and later Executive Chair and Non‑Executive Chair.( As a corporate insider at Xenon, he has helped build the company from a privately held cardiovascular and neuroscience-focused biotechnology venture into a Nasdaq‑listed biopharmaceutical company advancing late‑stage therapies for neurological disorders.(
Pimstone’s career combines clinical medicine, academic research in cardiovascular genetics, and leadership in the life sciences industry.( He trained in medicine at the University of Cape Town (MB ChB), completed a PhD in Medicine/cardiovascular genetics at the University of Amsterdam, and obtained his FRCPC in Internal Medicine from the University of British Columbia (UBC).( In parallel with his executive roles, he continues to practice as a consultant physician at UBC Hospital’s Cardiology Clinic and serves as a Clinical Associate Professor in UBC’s Division of General Internal Medicine, while also holding board and chair positions at several pharmaceutical and life sciences organizations.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.